These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22350261)

  • 21. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD40 activation in human pancreatic islets and ductal cells.
    Klein D; Timoneri F; Ichii H; Ricordi C; Pastori RL
    Diabetologia; 2008 Oct; 51(10):1853-61. PubMed ID: 18661119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein A-I inhibits CD40 proinflammatory signaling via ATP-binding cassette transporter A1-mediated modulation of lipid raft in macrophages.
    Yin K; Chen WJ; Zhou ZG; Zhao GJ; Lv YC; Ouyang XP; Yu XH; Fu Y; Jiang ZS; Tang CK
    J Atheroscler Thromb; 2012; 19(9):823-36. PubMed ID: 22786446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo.
    Dormond O; Contreras AG; Meijer E; Datta D; Flynn E; Pal S; Briscoe DM
    J Immunol; 2008 Dec; 181(11):8088-95. PubMed ID: 19018001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
    Sadeghlar F; Vogt A; Mohr RU; Mahn R; van Beekum K; Kornek M; Weismüller TJ; Branchi V; Matthaei H; Toma M; Schmidt-Wolf IGH; Kalff JC; Strassburg CP; González-Carmona MA
    Cancer Immunol Immunother; 2021 May; 70(5):1451-1464. PubMed ID: 33180184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autocrine TNF-α-mediated NF-κB activation is a determinant for evasion of CD40-induced cytotoxicity in cancer cells.
    Li D; Zhong Y; Zhou Y; Sun H; Zheng X; Zhao C; Yan Y; Lin Y; Liao L; Wang X
    Biochem Biophys Res Commun; 2013 Jul; 436(3):467-72. PubMed ID: 23751348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells: an autocrine anti-apoptotic role.
    Voorzanger-Rousselot N; Blay JY
    Leuk Lymphoma; 2004 Jun; 45(6):1239-45. PubMed ID: 15360007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of CD40 ligation combined with chemotherapy drugs on human breast cancer cell lines.
    Wang ZQ; Wang J; Ling WH; Zhang XG; Shi Q
    J Int Med Res; 2013 Oct; 41(5):1495-504. PubMed ID: 23934044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.
    Mineva ND; Rothstein TL; Meyers JA; Lerner A; Sonenshein GE
    J Biol Chem; 2007 Jun; 282(24):17475-85. PubMed ID: 17446175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts.
    Aldinucci D; Poletto D; Nanni P; Degan M; Rupolo M; Pinto A; Gattei V
    Exp Hematol; 2002 Nov; 30(11):1283-92. PubMed ID: 12423681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD40 ligand (CD40L) does not stimulate proliferation of vascular smooth muscle cells.
    Hermann A; Schrör K; Weber AA
    Eur J Cell Biol; 2002 Apr; 81(4):213-21. PubMed ID: 12018389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo.
    Melter M; Reinders ME; Sho M; Pal S; Geehan C; Denton MD; Mukhopadhyay D; Briscoe DM
    Blood; 2000 Dec; 96(12):3801-8. PubMed ID: 11090063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L system.
    Wischhusen J; Schneider D; Mittelbronn M; Meyermann R; Engelmann H; Jung G; Wiendl H; Weller M
    J Neuroimmunol; 2005 May; 162(1-2):28-42. PubMed ID: 15833357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12.
    Cong Y; Weaver CT; Lazenby A; Elson CO
    J Immunol; 2000 Aug; 165(4):2173-82. PubMed ID: 10925304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD40: an upstream master switch for endothelial cell activation uncovered by RNAi-coupled transcriptional profiling.
    Pluvinet R; Olivar R; Krupinski J; Herrero-Fresneda I; Luque A; Torras J; Cruzado JM; Grinyó JM; Sumoy L; Aran JM
    Blood; 2008 Nov; 112(9):3624-37. PubMed ID: 18669876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis.
    Ramirez SH; Fan S; Dykstra H; Reichenbach N; Del Valle L; Potula R; Phipps RP; Maggirwar SB; Persidsky Y
    J Neurosci; 2010 Jul; 30(28):9454-64. PubMed ID: 20631174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.
    Bugajska U; Georgopoulos NT; Southgate J; Johnson PW; Graber P; Gordon J; Selby PJ; Trejdosiewicz LK
    J Natl Cancer Inst; 2002 Sep; 94(18):1381-95. PubMed ID: 12237284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells.
    Clodi K; Asgary Z; Zhao S; Kliche KO; Cabanillas F; Andreeff M; Younes A
    Br J Haematol; 1998 Oct; 103(1):270-5. PubMed ID: 9792321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.